Hospital infection rates: Canary in the mineshaft

Article

Five years after the Institute of Medicine issued To Err is Human, its devastating report on the toll of lives taken by medical errors, improvement is being made-but the pace is far too slow. Among indicators of how well, or poorly, hospitals do in protecting the safety of patients, one seems of unequalled potency: the hospital infection rate. That rate has risen by 20% in the past few years, according to a three-year study of 39 million Medicare hospitalizations performed by HealthGrades, and is the marker that correlates most highly with overall performance on a set of 13 patient safety indicators developed by the Agency for Healthcare Research and Quality (AHRQ). What can be concluded? The gap between hospitals that are good at protecting patients from error and those that are poor at it is getting wider.

The full text of the report, Healthgrades Patient Safety in American Hospitals, can be downloaded at http://www.healthgrades.com/ The report includes a listing of what the study finds to be the safest hospitals in the country.

But the news isn't thoroughly bad. According to Lucian Leape, MD, noted for his efforts to raise the consciousness of the health-care community about medical errors and their consequences, and who is quoted in the May 18, 2005, issue of JAMA, progress is being made-slowly.

Dr. Leape's coauthored article in JAMA (2005;293:2384) tabulates the clinical effectiveness of these and other safe practices.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Related Content
© 2025 MJH Life Sciences

All rights reserved.